(BHE) Benchmark Electronics - Ratings and Ratios
Design, Engineering, Manufacturing, Testing, Integration
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.73% |
| Yield on Cost 5y | 2.63% |
| Yield CAGR 5y | 0.94% |
| Payout Consistency | 98.9% |
| Payout Ratio | 29.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 34.5% |
| Value at Risk 5%th | 50.1% |
| Relative Tail Risk | -11.58% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.08 |
| Alpha | -24.35 |
| CAGR/Max DD | 0.51 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.372 |
| Beta | 1.281 |
| Beta Downside | 1.150 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.73% |
| Mean DD | 13.96% |
| Median DD | 12.76% |
Description: BHE Benchmark Electronics November 13, 2025
Benchmark Electronics Inc. (NYSE:BHE) delivers end-to-end product design, engineering, and manufacturing services across the Americas, Asia, and Europe, targeting OEMs in semiconductor capital equipment, industrial, medical, aerospace & defense, and advanced computing & communications.
Its core capabilities span new-product design, prototype testing, custom test and automation equipment, PCB assembly, functional and environmental stress testing, failure analysis, precision machining, electromechanical assembly, and full system integration, complemented by supply-chain management, aftermarket repair, refurbishment, and spare-parts services throughout a product’s lifecycle.
Key recent metrics (FY 2023) include revenue of roughly $1.1 billion, an operating margin of 4.2 %, and a backlog of $750 million, reflecting strong demand from aerospace & defense and semiconductor equipment sectors.
Sector drivers that materially affect BHE’s outlook are the ongoing global semiconductor equipment spend (projected CAGR ≈ 6 % through 2027) and rising U.S. defense budgets, which together underpin growth in high-mix, low-volume manufacturing contracts.
For a deeper quantitative assessment, you may find the ValueRay platform’s detailed financial models useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (37.3m TTM) > 0 and > 6% of Revenue (6% = 156.7m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -7.78pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 31.26% (prev 32.32%; Δ -1.06pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 111.2m > Net Income 37.3m (YES >=105%, WARN >=100%) |
| Net Debt (32.8m) to EBITDA (138.8m) ratio: 0.24 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (36.2m) change vs 12m ago -1.22% (target <= -2.0% for YES) |
| Gross Margin 10.08% (prev 10.15%; Δ -0.07pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 123.9% (prev 125.2%; Δ -1.32pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.12 (EBITDA TTM 138.8m / Interest Expense TTM 22.2m) >= 6 (WARN >= 3) |
Altman Z'' 4.42
| (A) 0.39 = (Total Current Assets 1.44b - Total Current Liabilities 618.9m) / Total Assets 2.07b |
| (B) 0.28 = Retained Earnings (Balance) 577.6m / Total Assets 2.07b |
| (C) 0.04 = EBIT TTM 91.7m / Avg Total Assets 2.11b |
| (D) 0.60 = Book Value of Equity 574.0m / Total Liabilities 958.1m |
| Total Rating: 4.42 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 48.04
| 1. Piotroski 4.0pt |
| 2. FCF Yield 4.54% |
| 3. FCF Margin 2.87% |
| 4. Debt/Equity 0.29 |
| 5. Debt/Ebitda 0.24 |
| 6. ROIC - WACC (= -4.33)% |
| 7. RoE 3.36% |
| 8. Rev. Trend -35.32% |
| 9. EPS Trend -21.62% |
What is the price of BHE shares?
Over the past week, the price has changed by +1.81%, over one month by -8.00%, over three months by +22.17% and over the past year by +0.43%.
Is BHE a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BHE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 47.3 | 5.1% |
| Analysts Target Price | 47.3 | 5.1% |
| ValueRay Target Price | 50.4 | 11.8% |
BHE Fundamental Data Overview January 12, 2026
P/S = 0.6194
P/B = 1.449
P/EG = 1.91
Beta = 1.041
Revenue TTM = 2.61b USD
EBIT TTM = 91.7m USD
EBITDA TTM = 138.8m USD
Long Term Debt = 212.6m USD (from longTermDebt, last quarter)
Short Term Debt = 3.78m USD (from shortTermDebt, last quarter)
Debt = 318.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 32.8m USD (from netDebt column, last quarter)
Enterprise Value = 1.65b USD (1.62b + Debt 318.2m - CCE 285.4m)
Interest Coverage Ratio = 4.12 (Ebit TTM 91.7m / Interest Expense TTM 22.2m)
EV/FCF = 22.03x (Enterprise Value 1.65b / FCF TTM 74.9m)
FCF Yield = 4.54% (FCF TTM 74.9m / Enterprise Value 1.65b)
FCF Margin = 2.87% (FCF TTM 74.9m / Revenue TTM 2.61b)
Net Margin = 1.43% (Net Income TTM 37.3m / Revenue TTM 2.61b)
Gross Margin = 10.08% ((Revenue TTM 2.61b - Cost of Revenue TTM 2.35b) / Revenue TTM)
Gross Margin QoQ = 9.89% (prev 10.08%)
Tobins Q-Ratio = 0.80 (Enterprise Value 1.65b / Total Assets 2.07b)
Interest Expense / Debt = 1.39% (Interest Expense 4.42m / Debt 318.2m)
Taxrate = 30.73% (6.33m / 20.6m)
NOPAT = 63.5m (EBIT 91.7m * (1 - 30.73%))
Current Ratio = 2.32 (Total Current Assets 1.44b / Total Current Liabilities 618.9m)
Debt / Equity = 0.29 (Debt 318.2m / totalStockholderEquity, last quarter 1.11b)
Debt / EBITDA = 0.24 (Net Debt 32.8m / EBITDA 138.8m)
Debt / FCF = 0.44 (Net Debt 32.8m / FCF TTM 74.9m)
Total Stockholder Equity = 1.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.77% (Net Income 37.3m / Total Assets 2.07b)
RoE = 3.36% (Net Income TTM 37.3m / Total Stockholder Equity 1.11b)
RoCE = 6.94% (EBIT 91.7m / Capital Employed (Equity 1.11b + L.T.Debt 212.6m))
RoIC = 4.71% (NOPAT 63.5m / Invested Capital 1.35b)
WACC = 9.04% (E(1.62b)/V(1.94b) * Re(10.63%) + D(318.2m)/V(1.94b) * Rd(1.39%) * (1-Tc(0.31)))
Discount Rate = 10.63% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.31%
[DCF Debug] Terminal Value 65.65% ; FCFF base≈143.0m ; Y1≈93.9m ; Y5≈42.8m
Fair Price DCF = 18.96 (EV 709.3m - Net Debt 32.8m = Equity 676.5m / Shares 35.7m; r=9.04% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -21.62 | EPS CAGR: -44.10% | SUE: -4.0 | # QB: 0
Revenue Correlation: -35.32 | Revenue CAGR: 1.95% | SUE: 1.29 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.55 | Chg30d=-0.038 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=2.49 | Chg30d=-0.053 | Revisions Net=-1 | Growth EPS=+6.6% | Growth Revenue=+4.9%
Additional Sources for BHE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle